E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 2/5/2014 in the Prospect News Structured Products Daily.

New Issue: HSBC prices $3.81 million return enhanced notes linked to four stocks

By Toni Weeks

San Luis Obispo, Calif., Feb. 5 - HSBC USA Inc. priced $3.81 million of 0% return enhanced notes due Feb. 19, 2015 linked to a basket of four equally weighted stocks, according to a 424B2 filing with the Securities and Exchange Commission.

The underlying companies are Actavis plc, Endo Health Solutions Inc., Mylan Inc. and Valeant Pharmaceuticals International, Inc.

The payout at maturity will be par plus 1.5 times any gain in the basket, up to a maximum return of 25.5%.

Investors will be exposed to any losses.

The final basket level will be the average of the component returns, with each component return calculated using the average of the closing prices of the respective stock on five trading days ending Feb. 13, 2015.

HSBC Securities (USA) Inc. is the underwriter, and J.P. Morgan Securities LLC is the agent.

Issuer:HSBC USA Inc.
Issue:Return enhanced notes
Underlying stocks:Actavis plc (Symbol: ACT), Endo Health Solutions Inc. (Symbol: ENDP), Mylan Inc. (Symbol: MYL) and Valeant Pharmaceuticals International, Inc. (Symbol: VRX), equally weighted
Amount:$3.81 million
Maturity:Feb. 19, 2015
Coupon:0%
Price:Par
Payout at maturity:If basket return is positive, par plus 1.5 times basket return; if basket return is negative, 1-to-1 exposure to decline
Initial share prices:$188.98 for Actavis, $65.88 for Endo Health, $45.41 for Mylan and $135.64 for Valeant
Final basket level:Average of component returns, with each component return calculated using the average of the stock's closing prices on five trading days ending Feb. 13, 2015
Pricing date:Jan. 31
Settlement date:Feb. 5
Underwriter:HSBC Securities (USA) Inc.
Agent:J.P. Morgan Securities LLC
Fees:1%
Cusip:40432XSA0

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.